Andrea Bertotti
Istituto Nazionale Biostrutture e Biosistemi · 586 works · 14,198 citations · h-index 49
Top works
- MET signalling: principles and functions in development, organ regeneration and cancer
- A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
- Stromal contribution to the colorectal cancer transcriptome
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- Interrogating open issues in cancer precision medicine with patient-derived xenografts
- The genomic landscape of response to EGFR blockade in colorectal cancer
- EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
- Intrinsic Resistance to MEK Inhibition in KRAS Mutant Lung and Colon Cancer through Transcriptional Induction of ERBB3
- HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
- Effective drug combinations in breast, colon and pancreatic cancer cells
- Adaptive mutability of colorectal cancers in response to targeted therapies
- Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas
- Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
- Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer
- Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations
- Sema3E–Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
- Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2 -Amplified Gastrointestinal Carcinomas